Friday, September 11, 2026

SK Hynix Moves Forward with Semiconductor Fab in Yongin to Support AI Memory Growth

SK Hynix has begun construction on its first semiconductor fab in Yongin, aiming to boost AI memory semiconductor production by 2027.

SILENT Executer: North Korea’s Missile Bureau Perfects New Nuke Weapon Without Kim—APEC Is A Diversion

North Korea launched a ballistic missile, marking its first since May. The regime's cautious reporting hints at a strategic narrative management.

Trump’s Proposed 15% Semiconductor Tariff: What South Korea’s 70% Memory Dominance Means

U.S. semiconductor tariffs may be announced, but experts doubt their implementation due to potential harm to domestic firms and rising prices.

Tag: Lilly

Novo Nordisk Launches Clinical Trials for Next-Gen Obesity Drug ZenaGamtide in Asia: What to Expect?

Novo Nordisk begins domestic Phase 3 trials for obesity treatment candidate ZenaGamtide, competing with Eli Lilly's market leader.

Novo Nordisk vs Eli Lilly: Is Weight Loss Advertising Misleading?

Novo Nordisk sues Eli Lilly for misleading ads on obesity drugs, claiming false comparisons and seeking corrective action in court.

[Lillie report] Lilly’s Pacific-facing innovation hub brings K-biotech future to Songdo

Lilly Gateway Labs in San Diego supports early-stage biotechs, expanding to Korea with Samsung Biologics to foster innovation.

Can Donanemab Expand Alzheimer’s Treatment to Lewy Body Dementia? Key Insights from Korean Lilly’s Latest Clinical Trials

Lilly has launched a global trial for Kisunla, targeting Lewy body dementia, aiming to expand its Alzheimer's treatment to this underserved area.

Top News

- Our Sponsors Ad -

Follow us